RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial for Tough-to-Treat blood cancer halted after two patients
Disease control TerminatedThis early-stage study aimed to test the safety and early effectiveness of a new oral drug, narazaciclib, combined with a steroid (dexamethasone) for adults with multiple myeloma that has returned or stopped responding to multiple prior treatments. The goal was to find a safe dos…
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Adriana Rossi • Aim: Disease control
Last updated Apr 04, 2026 07:51 UTC
-
Early test of new drug for Tough-to-Treat blood cancer halted
Disease control TerminatedThis early-stage study tested an experimental drug called AMG 420 in patients with multiple myeloma that had returned or stopped responding to at least three prior standard treatments. The main goals were to check the safety of two different dose levels and see if the drug showed…
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC